Stockholm

Invitation to Essity's Q2 2018 Press Conference

Retrieved on: 
Wednesday, June 20, 2018

STOCKHOLM, June 20, 2018 /PRNewswire/ -- The press conference held in connection with the publication of Essity's interim report for the second quarter of 2018 will also be available via webcast and it is possible to join by phone.

Key Points: 
  • STOCKHOLM, June 20, 2018 /PRNewswire/ -- The press conference held in connection with the publication of Essity's interim report for the second quarter of 2018 will also be available via webcast and it is possible to join by phone.
  • The subsequent press conference will be held at 09:00 CET at Essity's headquarters, Waterfront Building, Klarabergsviadukten 63, Stockholm, Sweden.
  • At the press conference, President and CEO Magnus Groth will present and answer questions regarding the report.
  • It is also possible to participate in the press conference by telephone by calling +44 (0) 203-009-57-10, +1-866-869-23-21, or +46 (0)8-506-921-85.

Securitas Expands its Operations in Turkey

Retrieved on: 
Friday, June 1, 2018

STOCKHOLM, June1, 2018 /PRNewswire/ -- Securitas has signed an agreement to acquire the security company Pronet Security (Pronet Gvenlik ve Dan.Hiz.

Key Points: 
  • STOCKHOLM, June1, 2018 /PRNewswire/ -- Securitas has signed an agreement to acquire the security company Pronet Security (Pronet Gvenlik ve Dan.Hiz.
  • and Sernet Services in Turkey, to expand its operations in the country.
  • Pronet Security is a top 5 security company in Turkey with annual sales of approximately MSEK 480 (MTRY 246) and more than 5 000 employees.
  • Securitas is the market leader in Turkey with more than 13000 employees and is also the leading systems integrator.

Alligator Bioscience Capital Markets Day Today on May, 29

Retrieved on: 
Tuesday, May 29, 2018

Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, today hosts a capital markets day in Stockholm.

Key Points: 
  • Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, today hosts a capital markets day in Stockholm.
  • The capital markets day takes place at GT 30, Grev Turegatan 30 in Stockholm.
  • The event will be conducted in English and there will be a simultaneous live conference call for those unable to attend in person.
  • The event will be available on Alligator's website www.alligatorbioscience.com and a recording will be made available after the event.

Alligator Bioscience Capital Markets Day Today on May, 29

Retrieved on: 
Tuesday, May 29, 2018

Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, today hosts a capital markets day in Stockholm.

Key Points: 
  • Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, today hosts a capital markets day in Stockholm.
  • The capital markets day takes place at GT 30, Grev Turegatan 30 in Stockholm.
  • The event will be conducted in English and there will be a simultaneous live conference call for those unable to attend in person.
  • The event will be available on Alligator's website www.alligatorbioscience.com and a recording will be made available after the event.

Catella: Demand Pressure in European Commercial Residential Markets - Yield Decreases Aren't Measured

Retrieved on: 
Wednesday, May 23, 2018

STOCKHOLM, May 23, 2018 /PRNewswire/ -- Catella Research examined the commercial residential markets of 59 cities in 19 European countries: the lowest yield in Stockholm, the highest in Krakow.

Key Points: 
  • STOCKHOLM, May 23, 2018 /PRNewswire/ -- Catella Research examined the commercial residential markets of 59 cities in 19 European countries: the lowest yield in Stockholm, the highest in Krakow.
  • In the 19 countries analyzed by Catella, a total transaction volume of EUR 48.1 billion was achieved in 2017.
  • Zurich is in second place with 1,007 /sqm and therefore ahead of Paris, where the average price is 10,030 /sqm.
  • "The demand pressure in the European commercial residential markets will sustain.

Belatchew Arkitekter Designs the Discus High Rise - Nacka City's New Landmark

Retrieved on: 
Friday, May 18, 2018

STOCKHOLM, May 18, 2018 /PRNewswire/ --Belatchew Arkitekter has, on behalf of Swedish real estate developer Sveafastigheter Utveckling, designed Discus, a new landmark high rise in central Nacka; a booming part of the Stockholm metropolitan area in Sweden.

Key Points: 
  • STOCKHOLM, May 18, 2018 /PRNewswire/ --Belatchew Arkitekter has, on behalf of Swedish real estate developer Sveafastigheter Utveckling, designed Discus, a new landmark high rise in central Nacka; a booming part of the Stockholm metropolitan area in Sweden.
  • Discus is a new landmark building in Nacka City, which with its characteristic irregular silhouette is designed to become a symbol of a growing metropolitan area.
  • "Discus is the first high rise in Nacka's most central parts, and with its strong form, the building will contribute to Nacka's exciting silhouette.
  • Discus clearly shows an architectural ambition that Nacka Municipality wants to see in future projects in Nacka City," says Nina man, City Architect, Nacka Municipality.

BioArctic Receives This Year's SwedenBIO Award

Retrieved on: 
Wednesday, May 16, 2018

STOCKHOLM, May 16, 2018 /PRNewswire/ --BioArctic AB today received the SwedenBIO Award 2018.

Key Points: 
  • STOCKHOLM, May 16, 2018 /PRNewswire/ --BioArctic AB today received the SwedenBIO Award 2018.
  • "We are pleased to present this year's SwedenBIO Award to BioArctic.
  • The award is a confirmation of BioArctic's contributions to the continued positive development of the Swedish life science industry," says Gunilla Osswald, CEO of BioArctic.
  • SwedenBIO is the national trade association for life science in Sweden and the SwedenBIO Award is the industry's own prize.